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have MRI abnormalities such as cartilage damage, bone marrow lesions,
or meniscal extrusion. Those with the medial regional pain were also
more likely to have meniscal damage (Table 1).
Table 1
Compartment-speciﬁc
MRI features*
Local Medial Joint Line
Pain (n =83)
Regional Medial Pain
(n =36)
Global Pain (n =27)
RRR [95%CI] RRR [95% CI] RRR [95% CI]
Cartilage damage 2.52 1.07 5.92 3.97 1.28 12.35 4.65 1.37 15.81
Bone marrow lesions 9.89 2.04 47.99 12.10 2.27 64.60 12.44 2.24 69.05
Synovitis/effusion** 0.99 0.46 2.14 1.62 0.61 4.28 0.94 0.31 2.79
Meniscal damage 1.46 0.56 3.77 3.72 1.10 12.60 2.65 0.77 9.11
Meniscal extrusion 1.08 0.47 2.49 8.77 2.18 35.23 3.46 1.00 12.05
*adjusted for age, sex and BMI and compared to knees with pain in the past 30 days; RRR= relative risk ratio,
CI = conﬁdence interval. ** Synovitis/effusion was read for the whole knee.
Based on the results from the table above, MRI features from the
medial compartment were then combined into a single multivariable,
multinomial model predicting each of the three patterns of knee pain.
In this single multivariate multinomial model taking into account all
the MRI features, bone marrow lesions were still signiﬁcantly associated
with local medial joint line pain, medial regional pain and global pain
when compared to no pain. RRRs and 95% CIs were 7.97 (1.48, 43.01),
8.56 (1.45, 50.4), and 8.04 (1.35, 48.0), respectively. Meniscal extrusion
was signiﬁcantly associated with medial regional pain, with an RRR of
6.76 (1.574, 29.05) after accounting for the other MRI abnormalities.
Conclusions: The presence of MRI-detected pathology was associated
with medial localized joint line pain, medial regional pain and global
pain patterns. Of note, meniscal extrusion was associated with the medial
regional knee pain pattern. The association of meniscal damage with
the medial regional knee pain pattern was no longer signiﬁcant after
accounting for meniscal extrusion. These ﬁndings may help to identify
more homogenous populations for targeted knee OA interventions.
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OSTEOARTHRITIS SEVERITY IS ASSOCIATED WITH INCREASED RISK
FOR DIABETES AND HEART DISEASE
G.A. Hawker, A. Warner, T. Simms. Women’s Coll. Hosp., Toronto, ON,
Canada
Purpose: Prior studies have documented increased rates of diabetes
and heart disease in individuals with versus without osteoarthritis (OA).
However, there is a paucity of research that has examined if OA severity
contributes independently to these relationships. Our study aim was to
evaluate the relationship between OA severity and prevalence of heart
disease and diabetes and the extent to which these relationships, if
found, were explained by common risk factors.
Methods: In a population cohort with hip and knee OA, standardized
interviews assessed sociodemographics, OA severity (WOMAC subscale
and summary scores), body mass index (BMI, from height and
weight), general health status (SF36) and comorbidity (list of 13 non-
musculoskeletal, MSK, conditions). Diabetes and heart disease were
deﬁned as present if the participant reported having ‘ever’ received a
diagnosis or received treatment in the past year. Logistic regression was
used to examine the association of OA severity with each of diabetes and
heart disease, ﬁrst unadjusted, then controlling for potential confounders
(age, sex, education, income, BMI and diabetes [heart disease model]).
We assessed for potential interactions between OA severity and age,
sex, education, and income, and between OA severity and diabetes on
heart disease. Statistical signiﬁcance was considered at a 2-tailed level
of 0.05.
Results: Participation rates were 80.6% and 75.4% for the rural and
urban regions, respectively. Analyses are based on 2,225 participants
with OA. Their mean age was 70.7 years, 72.0% were female and 96.1%
Caucasian; 81.1% reported ≤high school education and 63.9% reported an
annual income ≤ $20,000. WOMAC scores indicated moderate to severe
OA pain and disability. Participants’ mean BMI was 27.9 kg/m2; 38.8%
were overweight and 30.9% were obese. Three-quarters (73.1%) reported
receiving treatment for at least one other non-MSK chronic condition;
one-ﬁfth (22.5%) reported 3 or more comorbid conditions; 30.4% reported
heart disease and 16.8% reported diabetes. Unadjusted for other factors,
a 10-point increase in WOMAC summary scores was associated with
a 10% increase in the odds of self-reporting diabetes (odds ratio 1.10;
95% conﬁdence interval 1.04–1.16). This relationship was attenuated,
becoming non-signiﬁcant, after controlling for BMI. Unadjusted for other
factors, a 10-point increase in WOMAC summary scores was associated
with a 12% increase in the odds of reporting heart disease (odds ratio 1.12;
95% conﬁdence interval 1.06–1.17). In adjusted analyses, self-reported
heart disease was signiﬁcantly and independently associated with male
sex, lower income, and interactions between OA severity and each of age
(p value for the interaction = 0.015) and self-reported diabetes (p value
for the interaction = 0.02); the effect of a 10-point increase in WOMAC
summary scores on the odds of self-reporting heart disease decreased
with increasing age, but was signiﬁcantly greater at all ages among those
with than among those without comorbid diabetes. Results were similar
using the WOMAC pain or function subscale scores to deﬁne OA severity
(data not shown).
Conclusions: In a population cohort with moderately severe hip and
knee OA, the prevalence of comorbid diabetes and heart disease was
substantial and positively linked to increasing symptomatic OA severity.
For diabetes, this relationship was explained by a common risk factor,
obesity. For heart disease, this relationship remained signiﬁcant even
after controlling for common risk factors, and was stronger among
those with versus without comorbid DM. Prospective studies are needed
to further elucidate the causal relationships among these common
conditions.
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SERUM ADIPOKINES IN END-STAGE OSTEOARTHRITIS; COMPARISON
WITH HEALTHY CONTROLS AND RELATIONS WITH INTRA-ARTICULAR
JOINT CHARACTERISTICS
T.N. de Boer1, S.C. Mastbergen1, A.M. Huisman2, J.W. Bijlsma1,
F.P. Lafeber1. 1Rheumatology & Clinical Immunology, Univ. Med. Ctr.
Utrecht, Utrecht, Netherlands; 2Rheumatology, Sint Franciscus Gasthuis,
Rotterdam, Netherlands
Purpose: Obesity is an important risk factor for osteoarthritis (OA). The
body mass index (BMI) is strongly associated with the prevalence and
incidence of knee OA. It is established that metabolic factors exert an
extra systemic effect on top of the mechanical effect of overweight in OA.
Adipose tissue is considered an endocrine tissue that releases cytokines,
such as IL-1 and TNFa, as well as adipokines, such as adiponectin, leptin,
and resistin. Adipokines have been reported to be involved in the disease
process. The exact mechanisms by which adipokines exert their effects in
OA are still unclear. The aim of this study is to compare serum adipokines
in end-stage OA with healthy controls and to evaluate the relationship
of these serum adipokines with actual cartilage damage and synovial
inﬂammation in the affected joint.
Methods: 172 successive patients with severe knee OA selected for total
knee replacement (TKR) surgery were included at the Sint Franciscus
Gasthuis, Rotterdam. Serum was collected shortly before TKR surgery.
Additionally from a healthy control (HC) group of 132 individuals without
any sign of radiographic knee OA serum was collected as well. Of all end-
stage OA patients and healthy individuals characteristics were collected
and serum adipokine (adiponectin, leptin and resistin) levels measured
by ELISA. Of the OA patients cartilage and synovial tissue were collected
at joint replacement surgery. Histological damage and proteoglycan
turnover and histological inﬂammation and IL-1b and TNFa production
were measured of cartilage and synovium, respectively. The study was
conducted according to the declaration of Helsinki and received ethics
approval of the hospital.
Results: In OA patients adiponectin levels were inversely related with
BMI (R = −0.218, p = 0.004) and positively correlated with age (R =0.283,
p = 0.000). Levels were higher in women than in men (24±13 and
14±7mg/ml, p = 0.000). Leptin levels showed a positive correlation with
patients BMI (R =0.604, p = 0.004 and R=0.495, p = 0.000, for OA and
HC, respectively). Leptin levels were also higher in women than in
men (90±64 and 33±28ng/ml, p = 0.000 in OA; 22±11 and 5.3±3ng/ml,
p = 0.000 in HC). In OA, resistin levels were inversely related with age
(R = −0.206, p = 0.012). Resistin levels did not differ between women and
men.
For the OA patients, all three adipokines correlated positively with
synovial inﬂammation. For adiponectin, leptin and resistin with synovial
tissue IL-1b production (p =0.02 all (p = 0.04 for women), p = 0.09 all, and
p=0.02 men, respectively). For leptin and resistin with synovial tissue
histological inﬂammation (p =0.06 all (p = 0.02 in men) and p=0.09 all,
respectively). For resistin with TNFa (p =0.09 all, p = 0.02 for men). None
of the adipokines showed an association with histological or biochemical
cartilage characteristics.
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Conclusions: In this study we demonstrate that adipokine levels are
signiﬁcantly increased in end-stage knee OA patients considered for joint
replacement surgery when compared to a healthy control group. We also
demonstrate a clear relation of these adipokines with age and with BMI
and a clear difference between men and women. Most interestingly,
these serum (peripheral) adipokines correlated with local parameters of
inﬂammation of the OA joints. It is concluded that systemically measured
adipokines play a role in the OA disease process also locally at the joint
level.
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CARTILAGE IS NOT THE FIRST KNEE TISSUE TO DEGENERATE IN
ASSOCIATION WITH FEMALE HORMONAL ASPECTS
B.M. de Klerk, D. Schiphof, E.H. Oei, H. Weinans, A. Hofman, B. Koes,
S.M. Bierma-Zeinstra. Erasmus Univ. Med. Ctr., Rotterdam, Netherlands
Purpose: Osteoarthritis (OA) affects all joint tissues and currently it is not
known which tissue is actually affected ﬁrst. When studying prevalent
OA cases with radiography it is impossible to distinguish where in the
joint the degeneration of tissues started. Magnetic resonance imaging
(MRI) can visualize degeneration of individual tissues in an earlier stage
than radiography.
The development of OA can be inﬂuenced by high body weight in
various manners. Not only locally by higher biomechanical loading
of the knees, but also systemically by secretion of inﬂammatory
mediators and hormones. Hormonal levels change around the time of
menopause, concurrently with an increased incidence of OA in women.
This simultaneous occurrence of menopause and increased OA incidence
suggests a role for female hormones, which has been suggested for a long
time, but the exact underlying mechanism has not yet been elucidated.
To gain insight into where degeneration of joint tissues starts in relation
to female hormonal aspects, we studied cross-sectional associations of
female hormonal determinants with the prevalence of early degenerative
signs in knee tissues on MRI.
Methods: Data of the RS-III-1 cohort of the Rotterdam study (a
population based cohort study) was used. Eligible participants for the
present study were females aged 45–60 years who had no OA in both
knees (Kellgren and Lawrence grade 0 or 1 on radiography) and for
whom knee MRI data was available. The effect of risk factors may differ
according to BMI, therefore we subdivided women according to BMI
category: women with high BMI (≥27) and women with low/normal BMI
(<27). In total 466 women with normal BMI (mean age 53.5 (SD 3.69),
932 knees) and 357 women with high BMI (mean age 53.8 (SD 3.97),
714 knees) were included.
General Estimating Equations analysis was used, with ‘knee side’
as within-subject variable, to test the associations between female
hormonal aspects and degenerative signs of knee tissues. The hormonal
aspects tested were: natural menopause (PostMP), age at menarche,
current use of hormone replacement therapy (HRT) and years since
menopause (YSM). Tissues assessed for degenerative signs were:
meniscus, cartilage, and bone (osteophytes and bone marrow lesions
(BMLs)). In addition, joint effusion was studied.
Results: Of the included knees 17.8% had a KL-grade 1 in the high BMI
group and 13.0% in the low/normal BMI group. In overweight women we
found that being PostMP was signiﬁcantly associated with the presence
of osteophytes in the tibiofemoral joint (OR=2.31 (1.12–4.83) and YSM
with presence of BMLs (OR=1.05 (1.01–1.09)), but both associations were
not observed in normal weight women (PostMP-osteophytes: OR=0.98
(0.53–1.79), YSM-BML: OR=0.98 (0.95–1.01)). Having an early menarche
(<12 years old) was protective for degeneration of the lateral meniscus
in overweight women only (OR=0.39 (0.20–0.77). Current use of HRT
seemed to be signiﬁcantly protective for joint effusion in overweight
women only (OR=0.18 (0.04–0.72). We did not ﬁnd any signiﬁcant
associations with cartilage degeneration.
Conclusions: We found indications that early signs of degeneration of
knee tissues, in relation with female hormonal aspects, may start in the
bone (bone marrow lesions and osteophytes), but not in cartilage.
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ADIPOSE STROMAL CELLS DOWN-MODULATE INFLAMMATORY
FACTORS IN SYNOVIOCYTES AND CHONDROCYTES FROM
OSTEOARTHRITIS PATIENTS
C. Manferdini1, A. Piacentini1, M. Maumus2, E. Gabusi1, J-A. Peyraﬁtte3,
C. Jorgensen2, A. Facchini1, D. Noel2, G. Lisignoli1. 1Istituto Ortopedico
Rizzoli, IOR, Bologna, Italy; 2Inserm, Montpellier, France; 3EFS-PM, Toulose,
France
Purpose: Osteoarthritis (OA) is a degenerative disease of the articular
joint that causes a degeneration of cartilage and for which no efﬁcient
treatments are available. It has been shown that adipose stromal cells
(ASC) have anti-ﬁbrotic, anti-inﬂammatory and anti-apoptotic properties,
through secreted growth factors, therefore can be good candidates for
preventing the evolution of OA disease. Therefore, the aim of the study
was the analysis of trophic potential effects of ASC on synoviocytes and
chondrocytes from OA patients.
Methods: ASC were isolated from intra-articular (Hoffa-ASC) or hip
(hip-ASC) subcutaneous adipose tissue of OA patients. Synoviocytes
and chondrocytes were isolated from synovium and cartilage of OA
patients undergoing total joint replacement. ASC were seeded in a
transwell and co-incubated with synoviocytes or chondrocytes grown
in monolayer for 7 days. Speciﬁc markers of inﬂammation (IL1b, IL6, IL8
and TNFa) were tested by RT-qPCR analysis and secreted factors (IL6,
IL17, CXCL8/IL8, CCL2/MCP-1, CCL3/MIP-1a, CCL5/RANTES,) by multiplex
bead-based sandwich immunoassay.
Results: Synoviocytes expressed higher basal levels of mRNA for IL1b,
IL6, IL8 and TNFa than chondrocytes. Both Hoffa-ASC or hip-ASC were
able to down-modulate the expression of IL1b, IL6, IL8 on synoviocytes
while only the expression of IL1b and IL6 were signiﬁcantly reduced
on chondrocytes. IL1b and TNFa were not secreted while IL6, IL8, IL17,
MCP-1, MIP-1a, RANTES were highly produced by both synoviocytes and
chondrocytes. Chondrocytes secreted approximately three times more
IL6, IL8 and MCP-1 than synoviocytes, while MIP1a was secreted eight
fold more than chondrocytes and no differences were measured for IL17
and RANTES. Hoffa-ASC alone produced higher level of RANTES and
IL17 than hip-ASC, however both ASC types signiﬁcantly decreased IL6,
IL8, IL17, MCP-1, MIP-1a, RANTES secretion of both chondrocytes and
synoviocytes.
Conclusions: These data demonstrate that ASC even if derived from
two different sources were able to produce trophic factors that exert
anti-inﬂammatory effects on both synoviocytes and chondrocytes so
corroborating their potential use in preventing OA evolution.
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THE EFFECT OF BARIATRIC SURGERY ON THE RESOLUTION AND
SEVERITY OF OSTEOARTHRITIS AND OTHER OBESITY-RELATED
COMORBIDITIES
J.X. Liu, J.K. Saunders, M. Parikh, S.B. Abramson. NYU Hosp. for Joint
Diseases, New York, NY, USA
Purpose: The purpose of this study was to objectively assess the
resolution ofosteoarthritis and other obesity-related comorbidities (ORC)
after bariatric surgery and to compare the status and resolution
ofosteoarthritis and other ORCs following laparoscopic adjustable
gastric banding (LAGB), roux-en-Y gastric bypass (RYGB), and sleeve
gastrectomy (LSG).
Methods: Data was collected from an IRB-approved electronic registry,
including patient demographics, weight, BMI, and ORC status. Using the
registry, osteoarthritis, as well as nine other ORCs were scored, pre-op
and post-op, from 0–5 according to severity using the Assessment of
Obesity-Related Comorbidities (AORC) Scale, the basis for the Bariatric
Outcomes Longitudinal Database. The ten ORCs were: osteoarthritis (OA),
diabetes, hypertension (HTN), obstructive sleep apnea, hyperlipidemia
(HLD), gastroesophageal reﬂux disease (GERD), depression, urinary stress
incontinence, hernia, and lower extremity edema (LEE). Resolution
of disease was deﬁned as having AORC > 0 pre-surgery and AORC=0
post-surgery. Change in ORC status was calculated with the following
equation: (pre-op AORC score) − (post-op AORC score). Paired t-tests were
utilized to determine whether comorbidity score change was signiﬁcant
following bariatric surgery. Fisher’s exact tests were used to determine if
there was a signiﬁcant difference in ORC resolution between procedures.
Results: 264 patients with ORC underwent bariatric surgery between
January 2008 and March 2010 at an urban safety-net hospital. Average
pre-op age was 42.5, and average pre-op BMI was 44.2. At mean patient
